PMID- 23556085 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20130405 LR - 20211021 IS - 2040-6207 (Print) IS - 2040-6215 (Electronic) IS - 2040-6207 (Linking) VI - 2 IP - 3 DP - 2011 Jun TI - High Prevalence of Obesity in Acute Promyelocytic Leukemia (APL): Implications for Differentiating Agents in APL and Metabolic Syndrome. PG - 141-5 LID - 10.1177/2040620711408490 [doi] AB - BACKGROUND: Between January 1999 and December 2008, 469 patients treated for acute myeloid leukemia (AML) were included in this single-institution study. METHODS: We performed a case-control analysis to study the rate of obesity among patients with acute promyelocytic leukemia (APL) and non-APL AML. RESULTS: A total of 81% of APL patients analyzed were obese compared with 41.7% in the non-APL group (p < 0.001). Body mass index (BMI) >30 was seen in 57% of APL patients compared with 31% for the non-APL group (p = 0.01). Neither obesity nor the chemotherapy dosing based on ideal body weight affected survival. CONCLUSIONS: Our findings generate the hypothesis that APL and metabolic syndromes may share a common pathogenic pathway via retinoic acid receptors (RARs), the ligand-controlled transcription factors that function as heterodimers with retinoid X receptors (RXRs) to regulate cell growth and survival. If this link is confirmed in larger studies, our data will instigate further studies using RXR and RAR modulators as a preventive strategy among obese individuals. FAU - Tedesco, Jason AU - Tedesco J AD - Department of Pathology, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. FAU - Qualtieri, Julianne AU - Qualtieri J FAU - Head, David AU - Head D FAU - Savani, Bipin N AU - Savani BN FAU - Reddy, Nishitha AU - Reddy N LA - eng GR - K12 CA090625/CA/NCI NIH HHS/United States PT - Journal Article PL - England TA - Ther Adv Hematol JT - Therapeutic advances in hematology JID - 101549589 PMC - PMC3573402 OTO - NOTNLM OT - RAR OT - RXR OT - acute promyelocytic leukemia OT - body mass index OT - obesity OT - prevention COIS- None declared. EDAT- 2011/06/01 00:00 MHDA- 2011/06/01 00:01 PMCR- 2011/06/01 CRDT- 2013/04/05 06:00 PHST- 2013/04/05 06:00 [entrez] PHST- 2011/06/01 00:00 [pubmed] PHST- 2011/06/01 00:01 [medline] PHST- 2011/06/01 00:00 [pmc-release] AID - 10.1177_2040620711408490 [pii] AID - 10.1177/2040620711408490 [doi] PST - ppublish SO - Ther Adv Hematol. 2011 Jun;2(3):141-5. doi: 10.1177/2040620711408490.